Robert V. Rawson
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 41
- Cutaneous Melanoma Detection and Management 31
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 9
-
- Melanoma and MAPK Pathways 17
- Protein Degradation and Inhibitors 2
- Co-authors
- Richard A. Scolyer (38 shared papers)John F. Thompson (17 shared papers)Georgina V. Long (23 shared papers)James S. Wilmott (16 shared papers)Peter M. Ferguson (11 shared papers)Serigne Lo (23 shared papers)Jeffrey E. Gershenwald (1 shared paper)Víctor G. Prieto (1 shared paper)
- Journals
- Pathology (7 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)Modern Pathology (3 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Robert V. Rawson
45 papers receiving 642 citations
Peers
Comparison fields: 5 of 63
- Oncology 445
- Immunology 122
- Dermatology 39
- Biophysics 21
- Cancer Research 44
Countries citing papers authored by Robert V. Rawson
This map shows the geographic impact of Robert V. Rawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. Rawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. Rawson more than expected).
Fields of papers citing papers by Robert V. Rawson
This network shows the impact of papers produced by Robert V. Rawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. Rawson. The network helps show where Robert V. Rawson may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert V. Rawson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2017 | 65 | |
| 3 | 2020 | 40 | |
| 4 | 2018 | 36 | |
| 5 | 2022 | 36 | |
| 6 | 2020 | 36 | |
| 7 | 2017 | 35 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 29 | |
| 10 | 2022 | 28 | |
| 11 | 2020 | 26 | |
| 12 | 2022 | 22 | |
| 13 | 2020 | 19 | |
| 14 | 2021 | 18 | |
| 15 | 2016 | 13 | |
| 16 | 2019 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2019 | 11 | |
| 19 | 2023 | 9 | |
| 20 | 2007 | 8 |
About Robert V. Rawson
Robert V. Rawson is a scholar working on Oncology, Molecular Biology, Immunology, Epidemiology and Cancer Research, having authored 49 papers that have together received 643 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (31 papers), Melanoma and MAPK Pathways (17 papers), Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (7 papers), Nonmelanoma Skin Cancer Studies (5 papers), Cancer Genomics and Diagnostics (4 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Oncology (445 citations), Immunology (122 citations), Dermatology (39 citations), Biophysics (21 citations) and Cancer Research (44 citations). Robert V. Rawson has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Richard A. Scolyer, John F. Thompson, Georgina V. Long, James S. Wilmott, Peter M. Ferguson, Serigne Lo, Jeffrey E. Gershenwald, Víctor G. Prieto, Robyn P.M. Saw and Alexander M. Menzies. Their work appears in journals such as Pathology, Journal of Clinical Oncology, Annals of Oncology, Modern Pathology and Journal of the European Academy of Dermatology and Venereology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.